Educational attainment of individuals with lymphangioleiomyomatosis is a determinant of timely diagnosis and treatment uptake
Abstract Background Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease predominantly affecting women. Despite the availability of FDA-approved treatments, mTOR inhibitors like sirolimus or everolimus, significant disparities persist in early diagnosis, treatment utilization, and pati...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2026-02-01
|
| Collection: | Orphanet Journal of Rare Diseases |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s13023-026-04284-8 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|